Recall Notices

After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available.

Ranitidine recall – Novitium Pharma LLC.

November 01, 2019

On October 25, 2019, Novitium Pharma LLC (Novitium) issued a voluntary recall of Ranitidine 150mg capsules, and 300mg capsules due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.
Learn more

Important recall notice: Ranitidine recall – Sanofi

November 01, 2019

 

Updated: 10/30/19

On October 22, 2019, Sanofi issued a voluntary recall of Zantac OTC (over-the-counter) products due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.

Express Scripts will mail letters to patients who have received medication impacted by the recall.

The FDA recommends speaking with your prescriber if you want to stop your medication or use an alternative medication.

Zantac OTC (over-the-counter) Products:

Zantac 150®

Zantac 150® Cool Mint

Learn more

Important recall notice: Ranitidine recall – Sandoz Inc.

November 01, 2019

Updated: 10/30/19

On September 23, 2019, Sandoz, Inc. announced issued a voluntary recall of all lots of Ranitidine capsules due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.

Express Scripts will mail letters to patients who have received medication impacted by the recall.

The FDA recommends speaking with your prescriber if you want to stop your medication or use an alternative medication.

Learn more

Losartan, Losartan/HCTZ recall manufactured by Torrent

September 23, 2019

On September 19, 2019, Torrent Pharmaceutical announced an expanded recall of specific lots of Losartan tablets (50mg and 100mg), and Losartan/hydrochlorothiazide tablets (50mg/12.5mg and 100mg/25mg) due to the detection of an unexpected impurity (NMBA) found in the active pharmaceutical ingredient.
Learn more

Losartan Recall - Teva Pharmaceuticals/Golden State Medical Supply

June 12, 2019

Teva Pharmaceuticals announced a recall of specific lots for Losartan 25mg tabs (6 lots) and Losartan 100mg tablets (29 lots) due to due to the detection of an unexpected impurity N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) found in the active pharmaceutical ingredient manufactured by Hetero Labs Limited.
Learn more

The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.